Your session is about to expire
← Back to Search
Spinal Cord Stimulation + Rehabilitation for Stroke (HARNESS Trial)
HARNESS Trial Summary
This trial seeks to find if non-invasive spinal stimulation combined with activity-based rehabilitation can improve hand and arm movement in people with a stroke.
HARNESS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHARNESS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HARNESS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had a seizure more than a month after having a stroke.I have severe stiffness in my hand and arm joints.My arm and hand movement ability is moderately impaired.It has been over 6 months since my stroke.I am currently taking medication for anxiety, muscle spasms, blood thinning, or seizures.I take more than 30 mg of baclofen daily.I had a stroke that caused weakness or paralysis on one side of my body.I have the support needed to attend all sessions for 8 months.I can attend sessions three times a week.I haven't changed my baclofen dose in the last 4 weeks.I have significant memory or thinking problems.You have a pacemaker or other implanted device that helps your body function.I have had a bleeding stroke.I have had more than one stroke.You have difficulty speaking or understanding that would make it hard for you to take part in the study.You have difficulty noticing or paying attention to one side of your body.I have not had botulinum toxin injections in my arm muscles in the last 6 months.I have severe muscle stiffness in my arm.
- Group 1: Activity Based Rehabilitation
- Group 2: Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment for this scientific experiment still underway?
"Affirmative. Data hosted on clinicaltrials.gov indicates that this research venture, which was first circulated on October 1st 2022, is actively seeking volunteers. Approximately 6 participants are needed from a single medical site."
Does the eligibility for this trial extend beyond those aged 65 and below?
"The protocol of this trial requires that candidates are at least 21 years old and not older than 80."
How many participants are included in the current research?
"Affirmative. Data hosted on clinicaltrials.gov points to the fact that this medical study, which was first posted on October 1st 2022, is currently recruiting patients. Approximately 6 people are sought from one site for participation in the trial."
Who qualifies to be involved in this medical trial?
"This trial is recruiting 6 participants with chronic stroke ranging between 21 and 80 years of age. To be eligible, they must possess the capacity to attend three sessions per week; provide adequate social support throughout 8 months; comprehend English language through reading, speaking or listening; have had a single radiologically documented ischemic stroke resulting in hemiplegia/hemiparesis at least six months prior; demonstrate moderate-mild upper extremity Fugl-Meyer Assessment score (29-53 out of 66); remain medically and neurologically stable as determined by medical history combined with physical examination findings. Lastly, women who may become pregnant"
What are the intended outcomes of this research?
"The primary metric evaluated during this clinical trial, spanning approximately 8 months, is the Fugl-Meyer assessment of upper limb dexterity. Supporting secondary outcomes include Box and Blocks Test scores (measuring gross manual coordination), Stroke Impact Scale results (evaluating disability/health quality after stroke) and Spinally evoked motor potentials test values (electrophysiological tests)."
Share this study with friends
Copy Link
Messenger